日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The IL-4/13-induced production of M2 chemokines by human lung macrophages is enhanced by adenosine and PGE2

腺苷和 PGE2 可增强 IL-4/13 诱导的人类肺巨噬细胞产生 M2 趋化因子

Marion Brollo, Hélène Salvator, Stanislas Grassin-Delyle, Mathieu Glorion, Delphyne Descamps, Amparo Buenestado, Emmanuel Naline, Hermann Tenor, Angelica Tiotiu, Philippe Devillier

Topical Wound Treatment with a Nitric Oxide-Releasing PDE5 Inhibitor Formulation Enhances Blood Perfusion and Promotes Healing in Mice

使用释放一氧化氮的 PDE5 抑制剂制剂进行局部伤口治疗可增强小鼠的血液灌注并促进愈合

Maya Ben-Yehuda Greenwald, Yu-Hang Liu, Weiye Li, Paul Hiebert, Maria Zubair, Hermann Tenor, Tobias Braun, Reto Naef, Daniel Razansky, Sabine Werner

Clinical Relevance of the Anti-inflammatory Effects of Roflumilast on Human Bronchus: Potentiation by a Long-Acting Beta-2-Agonist

罗氟司特对人体支气管抗炎作用的临床意义:长效β-2-激动剂的增强作用

Hélène Salvator, Amparo Buenestado, Marion Brollo, Emmanuel Naline, Tatiana Victoni, Elisabeth Longchamp, Hermann Tenor, Stanislas Grassin-Delyle, Philippe Devillier

Roflumilast N-oxide prevents cytokine secretion induced by cigarette smoke combined with LPS through JAK/STAT and ERK1/2 inhibition in airway epithelial cells

罗氟司特 N-氧化物通过抑制气道上皮细胞中的 JAK/STAT 和 ERK1/2 来防止香烟烟雾与 LPS 结合诱导的细胞因子分泌

Tatiana Victoni, Florence Gleonnec, Manuella Lanzetti, Hermann Tenor, Samuel Valença, Luis Cristovão Porto, Vincent Lagente, Elisabeth Boichot

Roflumilast inhibits lipopolysaccharide-induced tumor necrosis factor-α and chemokine production by human lung parenchyma

罗氟司特抑制脂多糖诱导的人肺实质产生肿瘤坏死因子-α和趋化因子

Amparo Buenestado, Marie-Camille Chaumais, Stanislas Grassin-Delyle, Paul-André Risse, Emmanuel Naline, Elisabeth Longchampt, Hermann Tenor, Philippe Devillier

Pharmacological validation of Trypanosoma brucei phosphodiesterases as novel drug targets

布氏锥虫磷酸二酯酶作为新型药物靶点的药理学验证

Harry P de Koning, Matthew K Gould, Geert Jan Sterk, Hermann Tenor, Stefan Kunz, Edith Luginbuehl, Thomas Seebeck